If they get enough money to get through a pivotal/registrational trial to completion, and subsequentially get FDA approval, they will need to partner or sell the business.
I have no faith in this company's ability to scale out commercial operations. Perhaps I would give them more credit if they were able to sell a meaningful amount of CardioCel given the investment ($) that was poured into that. I hope they know this and aren't going to be driven by ego to go it alone.
I might sound like I am sour (because I am) but I generally want this company to be successful and if the product is as good as they claim it will be a good outcome for patients too.
AVR Price at posting:
$17.05 Sentiment: Hold Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)